The peptide inhibited RSK activation, stimulated apoptosis of HSC and blocked active fibrogenesis, preventing progression and inducing regression of liver fibrosis compared to control mice treated with CCl4. The gene discussed is RPS6KA3; the disease is Hepatic fibrosis.